Reglan and Lonox drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Reglan (metoclopramide hydrochloride) and Lonox (atropine sulfate; diphenoxylate hydrochloride). Common drug interactions include stomatitis among females and vomiting among males.

The phase IV clinical study analyzes what interactions people have when they take Reglan and Lonox. It is created by eHealthMe based on reports of 12 people who take the same drugs from the FDA, and is updated regularly.

What is Reglan?

Reglan has active ingredients of metoclopramide hydrochloride. It is often used in gastroparesis. eHealthMe is studying from 29,455 Reglan users. Check the latest studies of Reglan.

What is Lonox?

Lonox has active ingredients of atropine sulfate; diphenoxylate hydrochloride. eHealthMe is studying from 376 Lonox users. Check the latest studies of Lonox.



On Jul, 31, 2026

12 people who take Reglan and Lonox together, and have interactions are studied.

Reglan and Lonox drug interactions.

What are the common drug interactions of Reglan and Lonox, by gender? *:

female:

  1. Stomatitis (inflammation of mucous membrane of mouth)
  2. Febrile neutropenia (fever with reduced white blood cells)
  3. Infection
  4. Abdominal pain
  5. Ammonia increased
  6. Biliary dyskinesia (motility disorder that affects the gallbladder and sphincter of oddi)
  7. Cardiac failure
  8. Cardiac failure congestive
  9. Diarrhoea
  10. Hepatitis (inflammation of the liver)

male:

  1. Vomiting
  2. Anorexia (eating disorder characterized by immoderate food restriction and irrational fear of gaining weight)
  3. Abdominal pain
  4. Gastritis (inflammation of stomach)
  5. Mental status changes (general changes in brain function, such as confusion, amnesia (memory loss), loss of alertness, loss of orientation)
  6. Oesophageal ulcer (ulcer of oesophagus)
  7. Peritonitis bacterial (inflammation of the peritoneum, the thin tissue that lines the inner wall of the abdomen and covers most of the abdominal organs by bacterial)
  8. Blood creatinine increased
  9. Cytomegalovirus infection
  10. Dehydration (dryness resulting from the removal of water)

What are the common drug interactions of Reglan and Lonox, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

  1. Biliary dyskinesia (motility disorder that affects the gallbladder and sphincter of oddi)
  2. Pulmonary embolism (blockage of the main artery of the lung)

30-39:

n/a

40-49:

  1. Klebsiella infection
  2. Oesophageal candidiasis (fungal infection of oesophagus)
  3. Restlessness (not able to rest)
  4. Tremor (trembling or shaking movements in one or more parts of your body)
  5. Vomiting
  6. Abdominal pain
  7. Gastritis (inflammation of stomach)
  8. Herpes simplex (herpes simplex is a common viral infection)
  9. Mental status changes (general changes in brain function, such as confusion, amnesia (memory loss), loss of alertness, loss of orientation)
  10. Neurotoxicity (when the exposure to natural or artificial toxic substances, which are called neurotoxins, alters the normal activity of the nervous system)

50-59:

n/a

60+:

  1. Infection
  2. Cardiac failure
  3. Cardiac failure congestive
  4. Peritonitis bacterial (inflammation of the peritoneum, the thin tissue that lines the inner wall of the abdomen and covers most of the abdominal organs by bacterial)
  5. Vomiting

What are the existing conditions these people have? *

  1. Colorectal Cancer Metastatic (cancer of colon and rectal spreads to other parts): 3 people, 25.00%
  2. Rheumatoid Arthritis (a chronic progressive disease causing inflammation in the joints): 2 people, 16.67%
  3. Pain: 2 people, 16.67%
  4. Nausea (feeling of having an urge to vomit): 2 people, 16.67%
  5. Migraine (headache): 2 people, 16.67%
  6. Diarrhea: 2 people, 16.67%
  7. Sleep Disorder: 1 person, 8.33%
  8. Gastritis (inflammation of stomach): 1 person, 8.33%
  9. Anaemia Of Malignant Disease: 1 person, 8.33%
  10. Birth Control: 1 person, 8.33%

* Approximation only. Some reports may have incomplete information.

Do you take Reglan and Lonox?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Reglan and Lonox:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Reglan:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Lonox:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Reglan and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Lonox and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

How the study uses the data?

The study uses data from the FDA. It is based on metoclopramide hydrochloride and atropine sulfate; diphenoxylate hydrochloride (the active ingredients of Reglan and Lonox, respectively), and Reglan and Lonox (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: